Clinical depression: An evidence-based integrative complementary medicine treatment model

Alternative Therapies in Health and Medicine

Volumn 17, Issue 4, 2011, Pages 26-37

  Sarris, Jerome ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; FOLIC ACID; OMEGA 3 FATTY ACID; S ADENOSYLMETHIONINE;

ALTERNATIVE MEDICINE; DEPRESSION; EVIDENCE BASED MEDICINE; HUMAN; HYPERICUM; INTEGRATIVE MEDICINE; LIFESTYLE; METHODOLOGY; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW;

5-HYDROXYTRYPTOPHAN; COMPLEMENTARY THERAPIES; DEPRESSIVE DISORDER; EVIDENCE-BASED MEDICINE; FATTY ACIDS, OMEGA-3; FOLIC ACID; HUMANS; HYPERICUM; INTEGRATIVE MEDICINE; LIFE STYLE; PHYTOTHERAPY; QUALITY OF LIFE; S-ADENOSYLMETHIONINE;

EID: 80054858389     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med. 2008;358(1):55-68.
2. American Psychiatric Association. Diagnostic And Statistical Manual of Mental Disorders. 4th Text Revision. Washington, DC: American Psychiatric Association; 2000.
3. World Health Organization. Mental ahealth: Depression. 2011. http://www.who.int/mental_health/management/depression/definition/en/. Accessed May 23, 2011.
4. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
5. Alonso J, Angermeyer MC, Bernert S, et al; ESEMeD/MHEDEA 2000 Investigators, European Study of the Epidemiology of Mental Disorders (ESEMeD) Project. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004; (420):21-27.
6. Berton O, Nestler EJ. New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci. 2006;7(2):137-151.
7. Folstein M, Liu T, Peter I, et al. The homocysteine hypothesis of depression. Am J Psychiatry. 2007;164(6):861-867.
8. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24-31.
9. Kessler RC. The effects of stressful life events on depression. Annu Rev Psychol. 1997;48:191-214.
10. Haeffel GJ, Grigorenko EL. Cognitive vulnerability to depression: exploring risk and resilience. Child Adolesc Psychiatr Clin N Am. 2007;16(2):435-448, x.
11. Levinson DF. The genetics of depression: a review. Biol Psychiatry. 2006;60(2):84-92.
12. Tennant C. Life events, stress and depression: a review of recent findings. Aust N Z J Psychiatry. 2002;36(2):173-182.
13. Paykel E. Life events and affective disorders. Acta Psychiatr Scand Suppl. 2003;(418):61-66.
14. Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: implications for prevention and treatment. Annu Rev Clin Psychol. 2005;1:255-291.
15. Parker G, Fletcher K. Treating depression with the evidence-based psychotherapies: a critique of the evidence. Acta Psychiatr Scand. 2007;115(5):352-359.
16. Ellis P; Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust N Z J Psychiatry. 2004;38(6):389-407.
17. Wolf NJ, Hopko DR. Psychosocial and pharmacological interventions for depressed adults in primary care: a critical review. Clin Psychol Rev. 2008;28(1):131-161.
18. Molina JA. Understanding the biopsychosocial model. Int J Psychiatry Med. 1983;13(1):29-36.
19. Di Stefano V. Holism and Complementary Medicine: Origins and Principles. Crows Nest, NSW: Allen & Unwin; 2006.
20. Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007;164(2):201-204.
21. Hierholzer R. Remission rates for depression in STAR*D study. Am J Psychiatry. 2006;163(7):1293; author reply 1293-1294.
22. Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009;26(3):279-288.
23. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR. The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep. 2007;9(6):449-459.
24. Bower P, Gilbody S. Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. Br J Psychiatry. 2005 Jan;186:11-17.
25. Leurs MT, Schaalma HP, Jansen MW, Mur-Veeman IM, St Leger LH, de Vries N. Development of a collaborative model to improve school health promotion in The Netherlands. Health Promot Int. 2005;20(3):296-305.
26. Sado M, Knapp M, Yamauchi K, et al. Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in Japan. Aust N Z J Psychiatry. 2009;43(6):539-547.
27. Cipriani A, Geddes JR, Furukawa TA, Barbui C. Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice. Can J Psychiatry. 2007;52(9):553-562.
28. Arroll B, Macgillivray S, Ogston S, et al. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Ann Fam Med. 2005;3(5):449-456.
29. Fournier J, DeRubeis R, Hollon S, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47-53.
30. Jureidini J, Tonkin A. Overuse of antidepressant drugs for the treatment of depression. CNS Drugs. 2006;20(8):623-632.
31. Lake J. Textbook of Integrative Mental Health Care. New York, NY: Thieme; 2007.
32. Zuess J. An integrative approach to depression: part 1-etiology. Complement Health Pract Rev. 2003;8(1):9-24.
33. Zuess J. An integrative approach to depression: part 2-assessment and treatment. Complement Health Pract Rev. 2003;8(2):99-115.
34. Sarris J, Kavanagh DJ. Kava and St John's wort: current evidence for use in mood and anxiety disorders. J Altern Complement Med. 2009;15(8):827-836.
35. Butterweck V. Mechanism of action of St John's wort in depression: what is known? CNS Drugs. 2003;17(8):539-562.
36. Kelly GS. Rhodiola rosea: a possible plant adaptogen. Altern Med Rev. 2001;6(3):293-302.
37. Schmidt M, Betti G, Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr. 2007;157(13-14):315-319.
38. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481-493.
39. Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nord J Psychiatry. 2007;61(5):343-348.
40. Hosseinzadeh H, Sadeghnia H. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine. 2007;14(4):256-262.
41. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 2000;69(2):228-232.
42. Williams AL, Girard C, Jui D, Sabina A, Katz DL. S-adenosylmethionine (SAMe) as treatment for depression: a systematic review. Clin Invest Med. 2005;28(3):132-139.
43. Shaw K, Turner J, Del Mar C. Are tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis. Aust N Z J Psychiatry. 2002;36(4):488-491.
44. Sarris J, Kavanagh DJ, Byrne G. Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. J Psychiatr Res. 2010;44(1):32-41.
45. Hibbeln JR. Fish consumption and major depression. Lancet. 1998;351(9110):1213.
46. Sanchez-Villegas A, Henriquez P, Figueiras A, Ortuño F, Lahortiga F, Martínez-González MA. Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr. 2007;46(6):337-346.
47. Sarris J, Schoendorfer N, Kavanagh D. Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments. Nutr Reviews. 2009;67(3):125-131.
48. Sorgi PJ, Hallowell EM, Hutchins HL, Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J. 2007 Jul 13;6:16.
49. Conklin SM, Manuck SB, Yao JK, Flory JD, Hibbeln JR, Muldoon MF. High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med. 2007;69(9):932-934.
50. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):259-269.
51. Tassoni D, Kaur G, Weisinger RS, Sinclair AJ. The role of eicosanoids in the brain. Asia Pac J Clin Nutr. 2008;17 Suppl 1:220-228.
52. Williams AL, Katz D, Ali A, Girard C, Goodman J, Bell I. Do essential fatty acids have a role in the treatment of depression? J Affect Disord. 2006;93(1-3):117-123.
53. Maciocia G. The Practice of Chinese Medicine: The Treatment of Diseases with Acupuncture and Chinese Herbs. London, England: Churchill Livingstone; 1994.
54. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62.
55. Beck AT, Ward CH, Mendelson M, MOck J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-571.
56. Wang SM, Kain ZN, White P. Acupuncture analgesia: I. The scientific basis. Anesth Analg. 2008;106(2):602-610.
57. Cabýoglu MT, Ergene N, Tan U. The mechanism of acupuncture and clinical applications. Int J Neurosci. 2006;116(2):115-125.
58. Akbaraly TN, Brunner EJ, Ferrie JE, Marmot MG, Kivimaki M, Singh-Manoux A. Dietary pattern and depressive symptoms in middle age. Br J Psychiatry. 2009;195(5):408-413.
59. Jacka FN, Pasco JA, Mykletun A, et al. Association of Western and traditional diets with depression and anxiety in women. Am J Psychiatry. 2010 Mar;167(3):305-11. Epub 2010 Jan 4.
60. Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH. Depression and folate status in the US Population. Psychother Psychosom. 2003;72(2):80-87.
61. Tolmunen T, Voutilainen S, Hintikka J, et al. Dietary folate and depressive symptoms are associated in middle-aged Finnish men. J Nutr. 2003;133(10):3233-3236.
62. Werbach M. Nutritional Influences on Illness. 2nd ed. Tarzana, CA: Third Line Press; 1996.
63. Haas EM. Staying Healthy With Nutrition. Berkeley, CA: Celestial Arts; 1992.
64. Brady KT, Verduin ML, Tolliver BK. Treatment of patients comorbid for addiction and other psychiatric disorders. Curr Psychiatry Rep. 2007;9(5):374-380.
65. Cargiulo T. Understanding the health impact of alcohol dependence. Am J Health Syst Pharm. 2007;64(5 Suppl 3):S5-S11.
66. Adams TB, Moore MT, Dye J. The relationship between physical activity and mental health in a national sample of college females. Women Health. 2007;45(1):69-85.
67. Deslandes A, Moraes H, Ferreira C, et al. Exercise and mental health: many reasons to move. Neuropsychobiology. 2009;59(4):191-198.
68. Sarris J, Kavanagh D, Newton R. Depression and exercise. J Compl Med. 2008;(3):48-50,61.
69. Pilkington K, Kirkwood G, Rampes H, Richardson J. Yoga for depression: the research evidence. J Affect Disord. 2005;89(1-3):13-24.
70. Donker T, Griffiths KM, Cuijpers P, Christensen H. Psychoeducation for depression, anxiety and psychological distress: a meta-analysis. BMC Med. 2009 Dec 16;7:79.
71. Markowitz JC. Evidence-based psychotherapies for depression. J Occup Environ Med. 2008;50(4):437-440.
72. Beck AT. The evolution of the cognitive model of depression and its neurobiological correlates. Am J Psychiatry. 2008;165(8):969-977.
73. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am. 1998;21(2):293-307.
74. Barnhofer T, Crane C, Hargus E, Amarasinghe M, Winder R, Williams JM. Mindfulness-based cognitive therapy as a treatment for chronic depression: A preliminary study. Behav Res Ther. 2009;47(5):366-373.
75. Loizzo J, Charlson M, Peterson J. A program in contemplative self-healing: stress, allostasis, and learning in the Indo-Tibetan tradition. Ann N Y Acad Sci. 2009 Aug;1172:123-147.
76. Jorm AF, Morgan AJ, Hetrick SE. Relaxation for depression. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007142.
77. Bell AC, D'Zurilla TJ. Problem-solving therapy for depression: a meta-analysis. Clin Psychol Rev. 2009;29(4):348-353.
78. Lau MA. New developments in psychosocial interventions for adults with unipolar depression. Curr Opin Psychiatry. 2008;21(1):30-36.
79. Goldapple K, Segal Z, Garson C, et al. Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry. 2004;61(1):34-41.
80. Linden DE. How psychotherapy changes the brain-the contribution of functional neuroimaging. Mol Psychiatry. 2006;11(6):528-538.
81. Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, Ho ML, Baxter LR. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry. 2001;50(3):171-178.
82. Heinrich LM, Gullone E. The clinical significance of loneliness: a literature review. Clin Psychol Rev. 2006;26(6):695-718.
83. Gilbert P, Allan S. The role of defeat and entrapment (arrested flight) in depression: an exploration of an evolutionary view. Psychol Med. 1998;28(3):585-598.
84. Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychological treatment of depression: a meta-analytic database of randomized studies. BMC Psychiatry. 2008 May 16;8:36.
85. Griffiths KM, Calear AL, Banfield M. Systematic review on Internet Support Groups (ISGs) and depression (1): Do ISGs reduce depressive symptoms? J Med Internet Res. 2009;11(3):e40.
86. Mossakowski KN. The influence of past unemployment duration on symptoms of depression among young women and men in the United States. Am J Public Health. 2009;99(10):1826-1832.
87. Morrell SL, Taylor RJ, Kerr CB. Jobless. Unemployment and young people's health. Med J Aust. 1998;168(5):236-240.
88. Nierenberg AA. Current perspectives on the diagnosis and treatment of major depressive disorder. Am J Manag Care. 2001;7(11 Suppl):S353-S366.
89. Kessler RC, Merikangas KR, Wang PS. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 2007;3:137-158.
90. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30(3):208-225.
91. Kumar P, Clark M, eds. Clinical Medicine: A Textbook for Students and Doctors. 5th ed. London, England: W. B. Saunders; 2002.
92. Gjerdingen D, Katon W, Rich DE. Stepped care treatment of postpartum depression: a primary care-based management model. Womens Health Issues. 2008;18(1):44-52.
93. Fava M, Mischoulon D. Folate in depression: efficacy, safety, differences in formulations, and clinical issues. J Clin Psychiatry. 2009;70 Suppl 5:12-17.
94. Hanley J, Stirling P, Brown C. Randomised controlled trial of therapeutic massage in the management of stress. Br J Gen Pract. 2003;53(486):20-25.
95. Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev. 2003;7(3):215-225.
96. Even C, Schröder C, Friedman S, Rouillon F. Efficacy of light therapy in nonseasonal depression: a systematic review. J Affect Disord. 2008;108(1-2):11-23.
97. Tsang HW, Chan EP, Cheung WM. Effects of mindful and non-mindful exercises on people with depression: a systematic review. Br J Clin Psychol. 2008;47(Pt 3):303-322.
98. Montgomery P, Dennis J. Physical exercise for sleep problems in adults aged 60+. Cochrane Database Syst Rev. 2002;(4):CD003404.
99. Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO. Exercise treatment for depression: efficacy and dose response. Am J Prev Med. 2005;28(1):1-8.
100. Sarris J, Kavanagh D. Conducting research in herbal and complementary medicine. Aust J Med Herbalism. 2009;20(1):19-26.
101. Linde K, Berner MM, Kriston L. St John's wort for major depression. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000448.
102. Roder C, Schaefer M, Leucht S. Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort [article in German]. Fortschr Neurol Psychiatr. 2004;72(6):330-343.
103. Werneke U, Horn O, Taylor DM. How effective is St John's wort? The evidence revisited. J Clin Psychiatry. 2004;65(5):611-617.
104. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a doubleblind, randomized pilot trial. J Ethnopharmacol. 2005;97(2):281-284.
105. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med. 2004 Sep 2;4:12.
106. Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res. 2005;19(2):148-151.
107. Lin PY, Su KP. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry. 2007;68(7):1056-1061.
108. Appleton KM, Hayward RC, Gunnell D, et al. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials. Am J Clin Nutr. 2006;84(6):1308-1316.
109. Coppen A, Shaw DM, Farrell JP. Potentiation of the antidepressive effect of a monoamine-oxidase inhibitor by tryptophan. Lancet. 1963;1(7272):79-81.
110. Glassman AH, Platman SR. Potentiation of a monoamine oxidase inhibitor by tryptophan. J Psychiatr Res. 1969;7(2):83-88.
111. Walinder J, Skott A, Carlsson A, Nagy A, Bjorn-Erik R. Potentiation of the antidepressant action of clomipramine by tryptophan. Arch Gen Psychiatry. 1976;33(11):1384-1389.
112. Papakostas GI, Alpert JE, Fava M. S-adenosyl-methionine in depression: a comprehensive review of the literature. Curr Psychiatry Rep. 2003;5(6):460-466.
113. Smith CA, Hay PP, Macpherson H. Acupuncture for depression. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD004046.
114. Wang H, Qi H, Wang B, et al. Is acupuncture beneficial in depression: a meta-analysis of 8 randomized controlled trials? J Affect Disord. 2008 Dec;111(2-3):125-134.
115. Leo R, Ligot JS Jr. A systematic review of randomized controlled trials of acupuncture in the treatment of depression. J Affect Disord. 2007;97(1-3):13-22.
116. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ. 2001;322(7289):763-767.
117. Doyne EJ, Ossip-Klein DJ, Bowman ED, Osborn KM, McDougall-Wilson IB, Neimeyer RA. Running versus weight lifting in the treatment of depression. J Consult Clin Psychol. 1987;55(5):748-754.
118. Cuijpers P, van Straten A, Andersson G, van Oppen P. Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909-922.